Prediction of adverse drug reactions in geriatric patients admitted to intensive care units

IF 1 Q4 PHARMACOLOGY & PHARMACY FARMACIA HOSPITALARIA Pub Date : 2024-11-01 DOI:10.1016/j.farma.2024.03.004
Fabiana Angelo Marques Carizio , Isabella do Vale de Souza , Thalita Zago Oliveira , Luana Sueli Silva , Natalia Chaguri Alves Rodrigues , Maria Olívia Barbosa Zanetti , Fabiana Rossi Varallo , Leonardo Régis Leira-Pereira
{"title":"Prediction of adverse drug reactions in geriatric patients admitted to intensive care units","authors":"Fabiana Angelo Marques Carizio ,&nbsp;Isabella do Vale de Souza ,&nbsp;Thalita Zago Oliveira ,&nbsp;Luana Sueli Silva ,&nbsp;Natalia Chaguri Alves Rodrigues ,&nbsp;Maria Olívia Barbosa Zanetti ,&nbsp;Fabiana Rossi Varallo ,&nbsp;Leonardo Régis Leira-Pereira","doi":"10.1016/j.farma.2024.03.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Intensive care units (ICUs) pose challenges in managing critically ill patients with polypharmacy, potentially leading to adverse drug reactions (ADRs), particularly in the elderly.</div></div><div><h3>Objective</h3><div>To evaluate whether the severity and clinical prognosis scores used in ICUs correlate with the prediction of ADRs in aged patients admitted to an ICU.</div></div><div><h3>Methods</h3><div>A cohort study was conducted in a Brazilian University Hospital ICU. APACHE II and SAPS 3 assessed clinical prognosis, while GerontoNet ADR Risk Score and BADRI evaluated ADR risk at ICU admission. Severity of the patients' clinical conditions was evaluated daily based on the SOFA score. ADR screening was performed daily through the identification of ADR triggers.</div></div><div><h3>Results</h3><div>1295 triggers were identified (median 30 per patient, IQR<!--> <!-->=<!--> <!-->28), with 15 suspected ADRs. No correlation was observed between patient severity and ADRs at admission (<em>p</em> <!-->=<!--> <!-->0.26), during hospitalization (<em>p</em> <!-->=<!--> <!-->0.91), or at follow-up (<em>p</em> <!-->=<!--> <!-->0.77). There was also no association between death and ADRs (<em>p</em> <!-->=<!--> <!-->0.28) or worse prognosis and ADRs (<em>p</em> <!-->&gt;<!--> <!-->0.05). Higher BADRI scores correlated with more ADRs (<em>p</em> <!-->=<!--> <!-->0.001).</div></div><div><h3>Conclusions</h3><div>These data suggest that employing the severity and clinical prognosis scores used in ICUs is not sufficient to direct active pharmacovigilance efforts, which are therefore indicated for critically ill patients.</div></div>","PeriodicalId":45860,"journal":{"name":"FARMACIA HOSPITALARIA","volume":"48 6","pages":"Pages 286-289"},"PeriodicalIF":1.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMACIA HOSPITALARIA","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1130634324000412","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Intensive care units (ICUs) pose challenges in managing critically ill patients with polypharmacy, potentially leading to adverse drug reactions (ADRs), particularly in the elderly.

Objective

To evaluate whether the severity and clinical prognosis scores used in ICUs correlate with the prediction of ADRs in aged patients admitted to an ICU.

Methods

A cohort study was conducted in a Brazilian University Hospital ICU. APACHE II and SAPS 3 assessed clinical prognosis, while GerontoNet ADR Risk Score and BADRI evaluated ADR risk at ICU admission. Severity of the patients' clinical conditions was evaluated daily based on the SOFA score. ADR screening was performed daily through the identification of ADR triggers.

Results

1295 triggers were identified (median 30 per patient, IQR = 28), with 15 suspected ADRs. No correlation was observed between patient severity and ADRs at admission (p = 0.26), during hospitalization (p = 0.91), or at follow-up (p = 0.77). There was also no association between death and ADRs (p = 0.28) or worse prognosis and ADRs (p > 0.05). Higher BADRI scores correlated with more ADRs (p = 0.001).

Conclusions

These data suggest that employing the severity and clinical prognosis scores used in ICUs is not sufficient to direct active pharmacovigilance efforts, which are therefore indicated for critically ill patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预测入住重症监护室的老年病人的药物不良反应。
导言:重症监护病房(ICU)在管理使用多种药物的重症患者时面临挑战,这可能导致药物不良反应(ADR),尤其是在老年人中:评估重症监护室使用的严重程度和临床预后评分是否与重症监护室收治的老年患者的药物不良反应预测相关:方法: 在巴西一所大学医院的重症监护室进行了一项队列研究。APACHE II和SAPS 3评估了临床预后,而GerontoNet ADR风险评分和BADRI评估了入住重症监护室时的ADR风险。每天根据 SOFA 评分评估患者临床状况的严重程度。每天通过识别 ADR 触发因素进行 ADR 筛查:结果:共识别出 1295 个诱发因素(中位数为每位患者 30 个,IQR=28),其中有 15 个疑似 ADR。在入院时(P=0.26)、住院期间(P=0.91)或随访时(P=0.77),均未观察到患者严重程度与 ADR 之间的相关性。死亡与 ADRs(P=0.28)或预后恶化与 ADRs(P>0.05)之间也没有关联。BADRI评分越高,ADR越多(p=0.001):这些数据表明,采用重症监护室中使用的严重程度和临床预后评分不足以指导积极的药物警戒工作,因此,重症患者应进行药物警戒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
FARMACIA HOSPITALARIA
FARMACIA HOSPITALARIA PHARMACOLOGY & PHARMACY-
CiteScore
1.90
自引率
21.40%
发文量
46
审稿时长
37 days
期刊介绍: Una gran revista para acceder a los mejores artículos originales y revisiones de la farmacoterapia actual. Además, es Órgano de expresión científica de la Sociedad Española de Farmacia Hospitalaria, y está indexada en Index Medicus/Medline, EMBASE/Excerpta Médica, Alert, Internacional Pharmaceutical Abstracts y SCOPUS.
期刊最新文献
Stability of thermolabile drugs at room temperature. A review. Criteria for medication reconciliation in major orthopedic surgery in high-risk patients: A consensus based on the Delphi method. Messenger RNA as a new strategy against cancer. Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis. [Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1